Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05637814 · ClinicalTrials.gov registry record · NA
Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements
A NA study of Congenital Heart Disease, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 3
- Study locations
NCT05637814 is a NA study of Congenital Heart Disease that has completed, run by University of California, Davis. The registered enrollment target is 51 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05637814, a NA study of Congenital Heart Disease, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to implement and externally validate an inpatient ML algorithm that combines pulse oximetry features for critical congenital heart disease (CCHD) screening.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST SpO2/PIx Measurement and ML Algorithm
Study Locations (3)
California
- UC Davis Medical Center - Davis
New York
- Cohen Children's Medical Center - Queens
Utah
- University of Utah Health Care - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2023-08-17 |
| Est. Completion | 2024-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05637814
The ClinicalTrials.gov registry entry for NCT05637814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (89% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which SpO2/PIx Measurement and ML Algorithm is the first listed.
NCT05637814 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, New York, Utah.
Frequently Asked Questions
What is clinical trial NCT05637814 about?
NCT05637814 is a clinical study titled "Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements". The purpose of this study is to implement and externally validate an inpatient ML algorithm that combines pulse oximetry features for critical congenital heart disease (CCHD) screening.
What is the current status of trial NCT05637814?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2023-08-17. Estimated completion is 2024-08-02.
What conditions does trial NCT05637814 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
What interventions are being tested in trial NCT05637814?
The interventions under investigation include: SpO2/PIx Measurement and ML Algorithm (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05637814?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05637814 being conducted?
This trial has 3 study locations across California, New York, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
-
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
RECRUITING · NA
-
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
RECRUITING · NA
-
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.